In 19 IC/BPS patients who received intravesical onabotulinumtoxinA injections compared with 12 healthy controls [72], the baseline nerve growth factor (NGF) mRNA levels in the bladders of IC/BPS patients were significantly greater than in the control patients. The gene discussed is NGF; the disease is Bartsocas-Papas syndrome 1.